rs745870220
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_014855.3(AP5Z1):c.2038G>A(p.Glu680Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000808 in 1,608,660 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014855.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AP5Z1 | NM_014855.3 | c.2038G>A | p.Glu680Lys | missense_variant | Exon 16 of 17 | ENST00000649063.2 | NP_055670.1 | |
AP5Z1 | NM_001364858.1 | c.1570G>A | p.Glu524Lys | missense_variant | Exon 15 of 16 | NP_001351787.1 | ||
AP5Z1 | XM_047421098.1 | c.1702G>A | p.Glu568Lys | missense_variant | Exon 14 of 15 | XP_047277054.1 | ||
AP5Z1 | NR_157345.1 | n.2169G>A | non_coding_transcript_exon_variant | Exon 16 of 17 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152130Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000835 AC: 2AN: 239506Hom.: 0 AF XY: 0.00000765 AC XY: 1AN XY: 130640
GnomAD4 exome AF: 0.00000824 AC: 12AN: 1456530Hom.: 0 Cov.: 32 AF XY: 0.00000414 AC XY: 3AN XY: 724238
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152130Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74310
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 48 Uncertain:1
This sequence change replaces glutamic acid with lysine at codon 680 of the AP5Z1 protein (p.Glu680Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has not been reported in the literature in individuals affected with AP5Z1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at